Acute and Long-term Outcomes of Patients With Acute Myocardial Infarction Treated With PCI

Acute and Long-term Outcomes of Patients Presenting With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04506047

Acronym

SINERGY-ACUTE

Enrollment

30000

Registered

2020-08-10

Start date

2009-01-01

Completion date

2025-01-31

Last updated

2022-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction, Coronary Artery Disease

Keywords

AMI

Brief summary

Randomized studies may often be burdened by the selective nature of patient inclusion thus not reflecting real-world outcomes. This is evident from the discrepancy in the mortality rates reported in major randomized trials enrolling patients with acute myocardial infarction (AMI), as compared with registry data. The primary objective of this observational study is to assess short- and long-term outcomes of unselected, real-world patients presenting with AMI and treated with contemporary percutaneous coronary intervention (PCI).

Interventions

PROCEDUREPercutaneous Coronary Intervention

Percutaneous Coronary Intervention

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with acute myocardial infarction referred to catheterization laboratory for percutaneous coronary intervention

Exclusion criteria

* Initial acute myocardial infarction diagnosis not confirmed * Patients with acute myocardial infarction not undergoing invasive coronary angiography

Design outcomes

Primary

Measure	Time frame	Description
Rate of all-cause mortality	1 year	Rate of all-cause mortality at 1 year

Secondary

Measure	Time frame	Description
Rate of all-cause mortality	5 years	Rate of all-cause mortality at 5 years
Rate of cardiovascular mortality	5 years	Rate of cardiovascular mortality at 5 years

Other

Measure	Time frame	Description
Rate of myocardial infarction	5 years	Rate of myocardial infarction at 5 years
Rate of new or worsening heart failure	5 years	Rate of new or worsening heart failure at 5 years
Rate of repeat revascularization	5 years	Rate of repeat revascularization at 5 years
Rate of stroke	5 years	Rate of stroke at 5 years

Countries

Serbia

Contacts

Primary ContactGoran Stankovic, MD, PhD

gorastan@gmail.com+381113613653

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026